April 29th 2025
Experts at Asembia’s AXS25 Summit discussed the economics of specialty pharmacy for rare diseases, addressing high treatment costs and strategies for balancing innovation.
Optical Coherence Tomography Could Reduce Age-Related Macular Degeneration Treatment Cost
January 10th 2018Use of optical coherence tomography as a guiding therapy for neovascular age-related macular degeneration resulted in an estimated accrued savings of $9 billion for the US government through Medicare.